Efficacy of Galcanezumab in Patients with Episodic Cluster Headaches and a History of Preventive Treatment Failure

被引：0
|
作者：
Plato, B. M. [1 ]
Andrews, J. [2 ]
Rettiganti, M. [2 ]
Tockhorn-Heidenreich, A. [2 ]
Bardos, J. [2 ]
Wenzel, R. [2 ]
Kuruppu, D. [2 ]
Ambrosini, A. [3 ]
机构：
[1] Norton Neurosci Inst, Louisville, KY USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] IRCCS Neuromed, Headache Clin, Pozzilli, Molise, Italy
来源：
HEADACHE | 2020年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [41] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine
    Quintana, Simone
    Russo, Marco
    Manzoni, Gian Camillo
    Torelli, Paola
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5757 - 5758
  • [42] Acute and Preventive Treatment Use in a Phase 3 Randomized Trial of Galcanezumab in Chronic Cluster Headache
    Lanteri-Minet, Michel
    Kalidas, Kavita
    Oakes, Tina M.
    Bardos, Jennifer
    Zhou, Chunmei
    Wenzel, Richard
    Yang, Jyun Yan
    NEUROLOGY, 2020, 94 (15)
  • [43] Acute and preventive treatment use in a phase 3 randomized trial of galcanezumab in chronic cluster headache
    Lanteri-Minet, Michel
    Kalidas, Kavita
    Oakes, Tina M.
    Bardos, Jennifer N.
    Zhou, Chunmei
    Wenzel, Richard
    Yang, Jyun Y.
    CEPHALALGIA, 2019, 39 : 58 - 58
  • [44] Comparison study between erenumab, fremanezumab, and galcanezumab in the preventive treatment of high frequency episodic migraine and chronic migraine
    Simone Quintana
    Marco Russo
    Gian Camillo Manzoni
    Paola Torelli
    Neurological Sciences, 2022, 43 : 5757 - 5758
  • [45] Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache (vol 80, pg 893, 2020)
    Scott, Lesley J.
    DRUGS, 2020, 80 (13) : 1379 - 1379
  • [46] Treatment with Galcanezumab in Patients with Episodic Migraine: Results from the OpenLabel Phase of the PERSIST Study
    Yu, Shengyuan
    Zhou, Jiying
    Zhuang, Junpeng
    Liu, Hui
    Qian, Chenxi
    NEUROLOGY, 2023, 100 (17)
  • [47] Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
    Kudrow, David
    Andrews, J. Scott
    Rettiganti, Mallikarjuna
    Oakes, Tina
    Bardos, Jennifer
    Gaul, Charly
    Riesenberg, Robert
    Wenzel, Richard
    Kuruppu, Dulanji
    Martinez, James
    HEADACHE, 2020, 60 (10): : 2254 - 2264
  • [48] Correction to: Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
    Xiuyuan Zhao
    Xiaolin Xu
    Qingyun Li
    Journal of Neurology, 2021, 268 : 2377 - 2378
  • [49] Diltiazem for the preventive treatment of episodic cluster headache: an open pilot study.
    Krymchantowski, AV
    Nobre, ME
    Moreira, PF
    CEPHALALGIA, 1999, 19 (04) : 457 - 457
  • [50] Acute and Preventive Treatment Use in a Phase-3 Randomized Trial of Galcanezumab in Chronic Cluster Headache
    Lanteri-Minet, Michel
    Kalidas, Kavita
    Oakes, Tina M.
    Bardos, Jennifer N.
    Zhou, Chunmei
    Wenzel, Richard
    Yang, Jyun Yan
    ANNALS OF NEUROLOGY, 2019, 86 : S244 - S245
12345